Economic evaluation of drug eluting stents: Cost-utility analysis

被引：0
|
作者：
Bischof, M. [1 ]
Briel, M. [1 ]
Bucher, H. C. [1 ]
Nordmann, A. [1 ]
机构：
[1] Univ Basel Hosp, CH-4031 Basel, BS, Switzerland
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63671-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A354 / A354
页数：1
相关论文
共 50 条
  • [1] Economic evaluation of drug-eluting stents:: A systematic literature review and model-based cost-utility analysis
    Kuukasjaervi, Pekka
    Raesaenen, Pirjo
    Malmivaara, Antti
    Aronen, Pasi
    Sintonen, Harri
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (04) : 473 - 479
  • [2] An economic evaluation of drug-eluting stents
    Shrive, FM
    Knudtson, ML
    Manns, BJ
    Ghali, WA
    CIRCULATION, 2004, 109 (20) : E236 - E236
  • [3] Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis
    Jesse Elliott
    Bláthnaid McCoy
    Tammy Clifford
    George A. Wells
    Doug Coyle
    PharmacoEconomics, 2018, 36 : 1253 - 1261
  • [4] Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis
    Elliott, Jesse
    McCoy, Blathnaid
    Clifford, Tammy
    Wells, George A.
    Coyle, Doug
    PHARMACOECONOMICS, 2018, 36 (10) : 1253 - 1261
  • [5] Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis
    Elliott, Jesse
    McCoy, Blathnaid
    Clifford, Tammy
    Potter, Beth K.
    Wells, George A.
    Coyle, Doug
    PHARMACOECONOMICS, 2020, 38 (09) : 971 - 980
  • [6] Economic evaluation of mental health interventions: an introduction to cost-utility analysis
    Luyten, Jeroen
    Naci, Huseyin
    Knapp, Martin
    EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (02) : 49 - 53
  • [7] Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis
    Jesse Elliott
    Bláthnaid McCoy
    Tammy Clifford
    Beth K. Potter
    George A. Wells
    Doug Coyle
    PharmacoEconomics, 2020, 38 : 971 - 980
  • [8] Drug-eluting stents from a Medicare payer perspective: Cost-utility analysis with 4-year clinical meta-analysis data
    Bischof, M.
    Briel, M.
    Bucher, H. C.
    Nordmann, A.
    VALUE IN HEALTH, 2008, 11 (03) : A202 - A202
  • [9] Cost-Effectiveness of Drug-Eluting Stents in a US Medicare Setting: A Cost-Utility Analysis with 3-Year Clinical Follow-Up Data
    Bischof, Matthias
    Briel, Matthias
    Bucher, Heiner C.
    Nordmann, Alain
    VALUE IN HEALTH, 2009, 12 (05) : 649 - 656
  • [10] Drug-eluting stents:: a systematic review and economic evaluation
    Hill, R. A.
    Boland, A.
    Dickson, R.
    Dundar, Y.
    Haycox, A.
    McLeod, C.
    Mota, R. Mujica
    Walley, T.
    Bagust, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (46) : 1 - +
12345